Under construction – not a live service
Sign in
Taking people in ChinaPhase 4

Studies a heart muscle biopsy procedure in people with heart disease

Tests a heart tissue sample procedure to confirm diagnoses in adults with heart conditions.

Plain-language title generated from the registry record
Registry title: Clinical Study of Endocardial Myocardial Biopsy

Key facts

Where
Hangzhou, ChinaSee the site
Phase
Phase 4

AI summary: who the study is looking for

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults aged 18-80 who are having an endocardial myocardial biopsy at one hospital, because of myocarditis, cardiomyopathy, heart failure or a cardiac tumor with an unknown cause.

Age
18 to 80 years
Sex
All sexes can join.
Disease stage
Myocarditis, cardiomyopathy, heart failure or cardiac tumor of unknown clinical cause.

Main reasons for not taking part

  • Cannot understand or does not want to sign the informed consent form
  • Cannot or does not want to follow the study visits

Read by machine on 12 November 2026.

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 80 years old?

Source: NCT05718128, who can take part

Where in China

  • 2nd Affiliated Hospital, School of Medicine, Zhejiang University, ChinaHangzhou, ChinaContact: XiaoHong PANTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Trial details

Who runs it
Second Affiliated Hospital, Zhejiang University, School of Medicine
Trial code
NCT05718128
Record updated
28 March 2023
Original description
In this study, patients with endocardial myocardial biopsy were selected to observe the safety of the operation, and pathological examination was performed. If necessary, special tests such as viral examination, mass spectrometry and molecular biology were performed to confirm the diagnosis, and follow-up was performed.Read full original descriptionShow less

Clinical Study of Endocardial Myocardial Biopsy

In this study, patients with endocardial myocardial biopsy were selected to observe the safety of the operation, and pathological examination was performed. If necessary, special tests such as viral examination, mass spectrometry and molecular biology were performed to confirm the diagnosis, and follow-up was performed.

Inclusion: Patients with no gender restriction, age 18-80 years old, receiving endocardial myocardial biopsy in the Second Affiliated Hospital of Zhejiang University School of Medicine; Patients with myocarditis, cardiomyopathy, heart failure and cardiac tumor of unknown clinical cause; Have the ability to understand the test, can cooperate with investigators.

Exclusion: Unable to understand or unwilling to fill in informed consent forms or follow visitors.

ClinicalTrials.gov NCT05718128